리파제

Emulsifiers in poultry nutrition-molecular mechanism of lipid metabolism and energy utilization: A meta-analysis and KEGG mapping.

1. Poult Sci. 2026 May;105(5):106603. doi: 10.1016/j.psj.2026.106603. Epub 2026 Feb 8. Emulsifiers in poultry nutrition-molecular mechanism of lipid metabolism and energy utilization: A meta-analysis and KEGG mapping. Adli DN(1), Sugiharto S(2), Ujilestari T(3), Irawan A(4), Azmi AFM(5), Illani

Oral Multienzyme Supplementation Alters Postprandial Plasma Nutrient Concentrations after a Mixed Meal in Healthy Middle-Aged and Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

2. J Nutr. 2026 Apr;156(4):101400. doi: 10.1016/j.tjnut.2026.101400. Epub 2026 Feb 7. Oral Multienzyme Supplementation Alters Postprandial Plasma Nutrient Concentrations after a Mixed Meal in Healthy Middle-Aged and Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.

Dual intestinal-hepatic modulation by phenolic acids improves metabolic-dysfunction associated steatohepatitis.

3. Biomed Pharmacother. 2026 Feb;195:119070. doi: 10.1016/j.biopha.2026.119070. Epub 2026 Jan 28. Dual intestinal-hepatic modulation by phenolic acids improves metabolic-dysfunction associated steatohepatitis. Amadi PU(1), Osuoha JO(2), Amadi JA(3), Efiong EE(4), Odika PC(5), Ekweogu CE(6), Eji

Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical Trial.

4. JAMA Oncol. 2026 Mar 1;12(3):243-250. doi: 10.1001/jamaoncol.2025.5751. Toripalimab vs Dacarbazine as First-Line Therapy for Advanced Melanoma of Acral Subtype: The Phase 3 MELATORCH Randomized Clinical Trial. Sheng X(1), Huang G(2), Fang M(3), Li K(4), Wu D(5), Zhang X(6), Chen J(7), Zhu D(8

Mediterranean and low-fat diets are equally effective in MASLD resolution at 12 weeks regardless of PNPLA3 genotype: A randomized controlled trial.

5. Hepatol Commun. 2025 Nov 24;9(12):e0856. doi: 10.1097/HC9.0000000000000856. eCollection 2025 Dec 1. Mediterranean and low-fat diets are equally effective in MASLD resolution at 12 weeks regardless of PNPLA3 genotype: A randomized controlled trial. Dogay Us G(1)(2)(3), Innocenti F(4), Koc OM(5

Clinical and Biological Efficacy of Thai Herbal Blood Lipid-Lowering Formulation for Borderline Hyperlipidemia: A Double-Blind Multicenter Randomized Controlled Trial.

6. J Evid Based Integr Med. 2025 Jan-Dec;30:2515690X251391671. doi: 10.1177/2515690X251391671. Epub 2025 Oct 27. Clinical and Biological Efficacy of Thai Herbal Blood Lipid-Lowering Formulation for Borderline Hyperlipidemia: A Double-Blind Multicenter Randomized Controlled Trial. Bunmee P(1)(2)

Phytosterols and Phospholipids Synergistically Improve Lipid Metabolism and Oxidative Stress: Evidence From Animal Model and Human Randomized Controlled Trials.

7. Mol Nutr Food Res. 2025 Nov;69(22):e70248. doi: 10.1002/mnfr.70248. Epub 2025 Sep 2. Phytosterols and Phospholipids Synergistically Improve Lipid Metabolism and Oxidative Stress: Evidence From Animal Model and Human Randomized Controlled Trials. Gao Y(1)(2), Pan D(1), Xia J(1), Xia H(1), Wan

Early Oral Refeeding in Patients with Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Randomized Controlled Trial.

8. Gut Liver. 2025 Nov 15;19(6):900-908. doi: 10.5009/gnl250110. Epub 2025 Aug 25. Early Oral Refeeding in Patients with Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Randomized Controlled Trial. Jo JH(1)(2), Lee JM(2)(3), Jang DK(2)(4), Choe JW(2)(5), Han SY(2)(6), Choi YH

Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis.

9. J Cyst Fibros. 2025 Nov;24(6):1043-1050. doi: 10.1016/j.jcf.2025.07.008. Epub 2025 Jul 31. Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis. Sathe M(1), Freedman SD(2), Putman MS(3), Gallotto R(4), Clarkin M(4), Gallott

A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma.

10. ESMO Open. 2025 Aug;10(8):105522. doi: 10.1016/j.esmoop.2025.105522. Epub 2025 Jul 25. A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcoma. Rosenbaum E(1), Seier K(2), Bradic M(3), Movva S(4), Kelly CM(4), Dick

Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial.

11. Nat Med. 2025 Aug;31(8):2632-2639. doi: 10.1038/s41591-025-03830-4. Epub 2025 Jul 10. Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial. Gaudet D(1), Gonciarz M(2), Shen X(2), Leohr JK(2), Beyer TP(2), Day JW

Synergistic antiviral effect of host Adipose Triglyceride Lipase-directed DABPU-DE with coronavirus RNA-dependent RNA polymerase-targeting remdesivir on feline infectious peritonitis virus.

12. J Gen Virol. 2026 Apr;107(4). doi: 10.1099/jgv.0.002261. Synergistic antiviral effect of host Adipose Triglyceride Lipase-directed DABPU-DE with coronavirus RNA-dependent RNA polymerase-targeting remdesivir on feline infectious peritonitis virus. Aboelmagd S(1)(2), Han SI(3), Farouk R(1)(4),

The synergistic effects of co-exposure of water disinfection byproducts DCBQ and DBBQ on lipid metabolism of mice.

13. Chem Biol Interact. 2026 Jun 1;432:112056. doi: 10.1016/j.cbi.2026.112056. Epub 2026 Mar 20. The synergistic effects of co-exposure of water disinfection byproducts DCBQ and DBBQ on lipid metabolism of mice. He Z(1), Han X(1), Zhang T(1), Yang Y(1), Jiang M(1), Zhang X(1), Du H(1), Lu R(1),

Chemical profiling and biological assessment of essential oil from Artemisia herba-alba.

14. Sci Rep. 2025 Aug 27;15(1):31538. doi: 10.1038/s41598-025-17221-9. Chemical profiling and biological assessment of essential oil from Artemisia herba-alba. Bsharat O(1), Salama Y(2), Al-Hajj N(3), Saed E(3), Jaradat N(4), Warad I(3), Al-Maharik N(5). Author information: (1)Department of Che

Synergistic evaluation of anti-diabetic and hypolipidemic effects of Alangium salvifolium and Ocimum sanctum extracts.

15. J Biomater Sci Polym Ed. 2026 Feb;37(3):450-478. doi: 10.1080/09205063.2025.2527254. Epub 2025 Jul 14. Synergistic evaluation of anti-diabetic and hypolipidemic effects of Alangium salvifolium and Ocimum sanctum extracts. Jain D(1), Sharma P(2), Jain V(3). Author information: (1)Department

Cistanoside F acts as a Monoacylglycerol Lipase inhibitor that synergizes the anti-tumor effect of 2-Arachidonoyl Glycerol on Bladder cancer.

7. Phytomedicine. 2025 Sep;145:157046. doi: 10.1016/j.phymed.2025.157046. Epub 2025 Jul 5. Cistanoside F acts as a Monoacylglycerol Lipase inhibitor that synergizes the anti-tumor effect of 2-Arachidonoyl Glycerol on Bladder cancer. Tan YJ(1), Ren YS(1), Lv JL(2), Zhao P(3), He Q(4), Lei XF(5),

Synergistic effect and mechanism of monoacylglycerol lipase inhibitor and Icaritin in the treatment of ulcerative colitis.

8. Int Immunopharmacol. 2024 Dec 5;142(Pt A):113155. doi: 10.1016/j.intimp.2024.113155. Epub 2024 Sep 13. Synergistic effect and mechanism of monoacylglycerol lipase inhibitor and Icaritin in the treatment of ulcerative colitis. Cui D(1), Li M(1), Liu M(2), Shen M(3), Liu Y(1), Wang K(4), Tang H

Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.

9. Neurotox Res. 2023 Dec;41(6):514-525. doi: 10.1007/s12640-023-00661-4. Epub 2023 Jul 17. Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.

Synergistic combination of Sapindoside A and B: A novel antibiofilm agent against Cutibacterium acnes.

5. Microbiol Res. 2022 Jan;254:126912. doi: 10.1016/j.micres.2021.126912. Epub 2021 Nov 1. Synergistic combination of Sapindoside A and B: A novel antibiofilm agent against Cutibacterium acnes. Wei MP(1), Yu H(1), Guo YH(1), Cheng YL(1), Xie YF(1), Yao WR(2). Author information: (1)State Key La

Triglyceride-Mimetic Structure-Gated Prodrug Nanoparticles for Smart Cancer Therapy.

3. J Med Chem. 2021 Nov 11;64(21):15936-15948. doi: 10.1021/acs.jmedchem.1c01328. Epub 2021 Nov 1. Triglyceride-Mimetic Structure-Gated Prodrug Nanoparticles for Smart Cancer Therapy. Tian C(1), Guo J(1), Miao Y(1), Zheng S(1), Sun B(1), Sun M(1), Ye Q(1), Liu W(2), Zhou S(1), Kamei KI(1)(3), H

Dangerous interaction of bitter melon (Momordica charantia) with pazopanib: A case of acute pancreatitis.

43. J Oncol Pharm Pract. 2022 Mar;28(2):486-488. doi: 10.1177/10781552211040725. Epub 2021 Sep 27. Dangerous interaction of bitter melon (Momordica charantia) with pazopanib: A case of acute pancreatitis. Unsal O(1), Sütcüoğlu O(1), Yazıcı O(1). Author information: (1)Department of Medical Onco

Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trial.

11. Diabetes Obes Metab. 2025 Jan;27(1):280-290. doi: 10.1111/dom.16014. Epub 2024 Oct 21. Efficacy and safety of cofrogliptin once every 2 weeks in Chinese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, phase 3 trial. Gao L(1), Bian F(2), Pan T(3), Jiang H(4), Fe

Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial.

10. Diabetes Obes Metab. 2024 Jul;26(7):2830-2838. doi: 10.1111/dom.15601. Epub 2024 Apr 11. Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial. Gu

Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors.

7. Cancer Med. 2024 Feb;13(3):e6877. doi: 10.1002/cam4.6877. Phase I study of sapanisertib (CB-228/TAK-228/MLN0128) in combination with ziv-aflibercept in patients with advanced solid tumors. Coleman N(1), Stephen B(1), Fu S(1), Karp D(1), Subbiah V(2), Ahnert JR(1), Piha-Paul SA(1), Wright J(3)

Heat-treated Pediococcus acidilactici LM1013-mediated inhibition of biofilm formation by Cutibacterium acnes and its application in acne vulgaris: A single-arm clinical trial.

22. J Cosmet Dermatol. 2023 Nov;22(11):3125-3134. doi: 10.1111/jocd.15809. Epub 2023 May 12. Heat-treated Pediococcus acidilactici LM1013-mediated inhibition of biofilm formation by Cutibacterium acnes and its application in acne vulgaris: A single-arm clinical trial. Bae WY(1), Jung WH(1), Lee

Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial.

25. Jpn J Clin Oncol. 2023 Jan 6;53(1):16-25. doi: 10.1093/jjco/hyac155. Adjuvant nivolumab versus placebo following radical surgery for high-risk muscle-invasive urothelial carcinoma: a subgroup analysis of Japanese patients enrolled in the phase 3 CheckMate 274 trial. Tomita Y(1), Kobayashi K(

The Combined Effects of Propionic Acid and a Mixture of Bacillus spp. Probiotic in a Plant Protein-Rich Diet on Growth, Digestive Enzyme Activities, Antioxidant Capacity, and Immune-Related Genes mRNA Transcript Abundance in Lates calcarifer Fry.

2. Probiotics Antimicrob Proteins. 2023 Jun;15(3):655-667. doi: 10.1007/s12602-021-09902-4. Epub 2022 Jan 8. The Combined Effects of Propionic Acid and a Mixture of Bacillus spp. Probiotic in a Plant Protein-Rich Diet on Growth, Digestive Enzyme Activities, Antioxidant Capacity, and Immune-Relat

Borage Oil Treated with Immobilized Lipase Inhibits Melanogenesis.

48. Lipids. 2020 Nov;55(6):649-659. doi: 10.1002/lipd.12266. Epub 2020 Jul 20. Borage Oil Treated with Immobilized Lipase Inhibits Melanogenesis. Shin JA(1), Sun M(1), Jeong JM(2). Author information: (1)Biotechnology Research Center, Ben's Lab., Co., Ltd., 17 Wauan-gil, Bongdam-eup, Hwasung-si,

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial.

3. Lancet Respir Med. 2020 Nov;8(11):1132-1143. doi: 10.1016/S2213-2600(20)30154-5. Epub 2020 May 29. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study):

Long-Term Effects of Orlistat on Lipid Metabolism and Anthropometric Indices: A Meta-Analysis of Clinical Trials.

15. J Obes. 2026 Feb 23;2026:9068305. doi: 10.1155/jobe/9068305. eCollection 2026. Long-Term Effects of Orlistat on Lipid Metabolism and Anthropometric Indices: A Meta-Analysis of Clinical Trials. Khodadadiyan A(1), Khazraei Y(1), Kamali M(1), Kolaei K(1), Aminzadeh P(1), Yazdanpanah G(1), Shams